Last reviewed · How we verify

NCT03555669

Project SOAR-Mental Health Malawi: Depression and HIV Integration

Completed NA Last updated 31 May 2023
What this trial tests

NA trial testing Depression Treatment in Depression in 2,082 participants. Completed in 31 May 2019.

Timeline
24 April 2017
Primary endpoint
31 May 2019
31 May 2019

Quick facts

Lead sponsorUniversity of North Carolina, Chapel Hill
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposehealth services research
Enrollment2,082
Start date24 April 2017
Primary completion31 May 2019
Estimated completion31 May 2019
Sites2 locations across Malawi

Drugs / interventions tested

Conditions studied

Sponsor

University of North Carolina, Chapel Hill

Who can join

18 and older, any sex, with Depression or HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Depression is highly prevalent among people living with HIV (PLHIV) in Malawi and elsewhere in sub-Saharan Africa (SSA). Besides its high prevalence, depression likely represents an important barrier to consistent HIV care engagement and long-term viral suppression. However, the potential for depression treatment to improve HIV care outcomes has received little attention in the region, in part because of limited mental health infrastructure. In this study, the investigators will evaluate the impact of a depression treatment program integrated within existing HIV clinics on depression response, retention in HIV care, and viral suppression. It is expected that this evaluation will yield important evidence on the impact of depression treatment integrated with HIV care for improving HIV care and mental health outcomes in Malawi.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Integrating depression management into HIV primary care in central Malawi: the implementation of a pilot capacity building program.
    Udedi M, Stockton MA, Kulisewa K, Hosseinipour MC, et al · · 2018 · cited 50× · PMID 30064418 · DOI 10.1186/s12913-018-3388-z
  2. The effectiveness of depression management for improving HIV care outcomes in Malawi: protocol for a quasi-experimental study.
    Udedi M, Stockton MA, Kulisewa K, Hosseinipour MC, et al · · 2019 · cited 15× · PMID 31242877 · DOI 10.1186/s12889-019-7132-3
  3. The acceptability of antidepressant treatment in people living with HIV in Malawi: A patient perspective.
    Kulisewa K, Minnick CE, Stockton MA, Gaynes BN, et al · · 2023 · cited 1× · PMID 37088107 · DOI 10.1080/17441692.2023.2201327

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03555669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing